Does SECUKINUMAB Cause Onychomadesis? 678 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 678 reports of Onychomadesis have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.5% of all adverse event reports for SECUKINUMAB.
678
Reports of Onychomadesis with SECUKINUMAB
0.5%
of all SECUKINUMAB reports
528
Deaths
530
Hospitalizations
How Dangerous Is Onychomadesis From SECUKINUMAB?
Of the 678 reports, 528 (77.9%) resulted in death, 530 (78.2%) required hospitalization, and 463 (68.3%) were considered life-threatening.
Is Onychomadesis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 678 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Onychomadesis?
ADALIMUMAB (797)
METHOTREXATE (785)
RITUXIMAB (722)
TOCILIZUMAB (721)
ABATACEPT (703)
INFLIXIMAB (682)
LEFLUNOMIDE (667)
GOLIMUMAB (660)
HYDROXYCHLOROQUINE (660)
CERTOLIZUMAB PEGOL (654)
Which SECUKINUMAB Alternatives Have Lower Onychomadesis Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG